UB Paderborn / Katalog / Suche / in CDI

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

Journal of clinical oncology, 2012-09, Vol.30 (26), p.3209-3216

2012

Link zum Volltext

Verfügbarkeit prüfen

Pathogenese, klinische Symptomatik und Komplikationen der PNH

InFo Hämatologie + Onkologie, 2024-04, Vol.27 (4), p.10-15

2024

Link zum Volltext

Verfügbarkeit prüfen

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

The lancet oncology, 2008-02, Vol.9 (2), p.105-116

2008

Link zum Volltext

Verfügbarkeit prüfen

Association of history of cerebrovascular disease with severity of COVID-19

Journal of neurology, 2021-03, Vol.268 (3), p.773-784

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results

International journal of infectious diseases, 2021-11, Vol.112, p.117-123

2021

Link zum Volltext

Verfügbarkeit prüfen

Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort

Scientific reports, 2022-11, Vol.12 (1), p.19035-19035, Article 19035

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease

Infection, 2021-08, Vol.49 (4), p.725-737

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy

Haematologica (Roma), 2008-03, Vol.93 (3), p.405-412

2008

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast Growth Factor Receptor 3 Mutations in Bladder Tumors Correlate with Low Frequency of Chromosome Alterations

Neoplasia (New York, N.Y.), 2008-01, Vol.10 (1), p.1-7

2008

Link zum Volltext

Verfügbarkeit prüfen

Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma

Journal of clinical oncology, 2014-04, Vol.32 (11), p.1112-1118

2014

Link zum Volltext

Verfügbarkeit prüfen

Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT

European journal of haematology, 2012-09, Vol.89 (3), p.214-219

2012

Link zum Volltext

Verfügbarkeit prüfen

The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells

The EMBO journal, 2011-02, Vol.30 (4), p.770-782

2011

Link zum Volltext

Verfügbarkeit prüfen

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

EMBO reports, 2008-06, Vol.9 (6), p.582-589

2008

Link zum Volltext

Verfügbarkeit prüfen

Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

British journal of haematology, 2013-07, Vol.162 (1), p.62-73

2013

Link zum Volltext

Verfügbarkeit prüfen

V707: Potency and Continence Preserving Radical Cystectomy with Hemiprostatectomy

The Journal of urology, 2006-04, Vol.175 (4), p.228-228

2006

Link zum Volltext

Verfügbarkeit prüfen

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

Nature cell biology, 2009-12, Vol.11 (12), p.1487-1495

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression of the human TSPY gene in the brains of transgenic mice suggests a potential role of this Y chromosome gene in neural functions

遗传学报, 2011, Vol.38 (5), p.181-191

Tatsuo Kido Stephanie Schubert Joerg Schmidtke Yun-Fai Chris Lau

2011

Link zum Volltext

Verfügbarkeit prüfen

Analysis of genetic alterations in normal bladder urothelium

Urology (Ridgewood, N.J.), 2003-12, Vol.62 (6), p.1134-1138

2003

Link zum Volltext

Verfügbarkeit prüfen

Second Line Therapy with Second Generation TKI After Intolerance to Imatinib Based Treatments Showed High Overall Survival in Contrast to Second Line Therapy After Resistance; Results of the Randomized CML Study IV

Blood, 2011-11, Vol.118 (21), p.781-781

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

Pathogenese, klinische Symptomatik und Komplikationen der PNH

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Association of history of cerebrovascular disease with severity of COVID-19

SARS-CoV-2 rapid antigen testing in the healthcare sector: A clinical prediction model for identifying false negative results

Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort

Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy

Fibroblast Growth Factor Receptor 3 Mutations in Bladder Tumors Correlate with Low Frequency of Chromosome Alterations

Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma

Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT

The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

Impact of Additional Cytogenetic Alterations At Diagnosis on Prognosis of CML: Long-Term Observation From 1151 Patients of the Randomized CML Study IV

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

V707: Potency and Continence Preserving Radical Cystectomy with Hemiprostatectomy

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

Expression of the human TSPY gene in the brains of transgenic mice suggests a potential role of this Y chromosome gene in neural functions

Analysis of genetic alterations in normal bladder urothelium

Time-Related Interpretation of Molecular Response Levels According to Long Term Overall and Progression-Free Survival of CML Patients on First-Line Imatinib Treatment

Second Line Therapy with Second Generation TKI After Intolerance to Imatinib Based Treatments Showed High Overall Survival in Contrast to Second Line Therapy After Resistance; Results of the Randomized CML Study IV

Suchergebnisse filtern